Qureight

Qureight is an AI-powered imaging contract research organisation (CRO). Its proprietary data and imaging curation platform handles image management, quality control and AI analysis of clinical imaging. Its deep-learning lung image biomarkers (Lung8, Air8, Fibr8, Glass8 and Vascul8) are described as built for interventional trials.

Customers are biopharma sponsors running trials in interstitial lung diseases, pulmonary hypertension and bronchiectasis. The company offers global imaging CRO services, AI-powered endpoints and analytics, and data science products such as synthetic control arms, sold together or individually.

The company states it is based in Cambridge and London, UK, and was founded by a team that combined respiratory medicine, radiology and machine learning. It lists 60 people and has open roles in machine learning, data engineering, clinical data management, platform engineering and clinical operations.

Product: Imaging data curation platform with AI lung imaging biomarkers and endpoints, delivered as a global imaging CRO service for clinical trials.